Company / Current Assets
Eledon Pharmaceuticals, Inc. Current Assets History
FY2014-FY2016 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$29.5M
FY2016
5-year range
$29.5M / $107.5M
FY2014-FY2016
Trend
-56.0%
vs FY2015
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $108M to $30M over the past 2 years.
Based on SEC 10-K filings.
$30M in FY2016.
Declined from $108M to $30M over the past 2 years.
Current Assets over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2016, current assets decreased 56.0% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -2.62 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2016 | $29.5M | -56.0% |
| FY2015 | $67.2M | -37.5% |
| FY2014 | $107.5M | - |
As of FY2016 · SEC 10-K · Updated Jun 24, 2026